Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT05083260

NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

A Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study in Parkinson's Disease (PD) Participants Treated With Carbidopa/Levodopa and NE3107

Sponsor: BioVie Inc.

Conditions Parkinson Disease

Interventions NE3107 placebo

Updated 11 times since 2021 Last updated: Feb 6, 2023 Started: Jan 4, 2022 Primary completion: Nov 21, 2022 Completion: Jan 4, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Parkinson Disease and is currently completed. BioVie Inc. leads this study, which shows 11 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Mar 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2

Status: Active Not Recruiting → Completed
Dec 2022 — Mar 2023 [monthly]

Active Not Recruiting PHASE1_PHASE2

▶ Show 6 earlier versions

Nov 2022 — Dec 2022 [monthly]

Active Not Recruiting PHASE1_PHASE2

Status: Recruiting → Active Not Recruiting
Sep 2022 — Nov 2022 [monthly]

Recruiting PHASE1_PHASE2
Jun 2022 — Sep 2022 [monthly]

Recruiting PHASE1_PHASE2
May 2022 — Jun 2022 [monthly]

Recruiting PHASE1_PHASE2
Feb 2022 — May 2022 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Nov 2021 — Feb 2022 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BioVie Inc.

Data source: BioVie Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Boca Raton, United States , Durham, United States , Englewood, United States , Farmington Hills, United States , Hallandale, United States , Lady Lake, United States , Miami, United States , New York, United States , Raleigh, United States , Sherman, United States and 3 more locations